NEW YORK, April 26, 2026 — Intel Corporation (INTC) closed at $82.73 on Sunday’s final tape, capping a week that reshaped the narrative around one of technology’s most scrutinised turnaround stories. Shares are +124% year-to-date and sit just 3.2% below the $85.22 all-time intraday high set on April 24 — a level that would have been unthinkable when the stock traded at $18.97 just twelve months ago. The catalyst was unambiguous: a first-quarter earnings report released after the close on April 23 that delivered an adjusted earnings-per-share beat of 2,800%, sending the stock up nearly 30% in pre-market trading before settling into a historic two-day surge. As PreMarket Daily reported, Intel surged 25%+ to $85.96 at the opening bell on April 24, and the S&P 500 closed at a record 7,165 that same session as Intel’s 23% gain carried the broader index.
The business and market position
Intel designs and manufactures microprocessors, chipsets, and related platform technologies for data centres, personal computers, and network infrastructure. The company operates two principal segments: Products, which encompasses the Client Computing Group (CCG), Data Center and AI Group (DCAI), and Network and Edge Group (NEX); and Intel Foundry, the contract manufacturing arm through which Intel produces chips for third-party customers on its own process nodes. After several years of market share erosion and process technology setbacks, Intel’s investor relations materials now reflect a company pivoting aggressively toward AI infrastructure as the dominant demand driver.
The strategic picture shifted materially this week on multiple fronts. Tesla confirmed it will use Intel’s forthcoming 14A process node for chips at the Terafab AI chip complex in Austin, Texas — a partnership that also encompasses SpaceX and Elon Musk’s xAI. Google separately committed to deploying multiple generations of Intel Xeon 6+ CPUs for AI workloads across its data centre infrastructure. These partnerships validate Intel’s manufacturing roadmap at a moment when agentic AI workloads are driving what the company described as “unprecedented” CPU demand alongside — rather than instead of — GPU infrastructure.
Perhaps the boldest capital allocation signal came with the Fab 34 buyout. Intel repurchased the 49% minority equity interest in its Fab 34 facility in Leixlip, Ireland, for $7.7 billion in cash plus $6.5 billion in new debt — a total commitment of $14.2 billion that concentrates full ownership of one of Europe’s most advanced semiconductor fabs in Intel’s hands. The move signals confidence in sustained demand for leading-edge manufacturing capacity, though it materially increases the company’s leverage profile.
The numbers
Q1 2026 earnings
Intel’s Q1 2026 results, released on April 23, delivered across every key metric. Adjusted EPS came in at $0.29 against a Wall Street consensus of $0.01 — a beat of 2,800%. GAAP EPS was -$0.73, burdened by a $3.9 billion goodwill impairment charge related to Mobileye. Revenue of $13.58 billion exceeded the $12.42 billion consensus by $1.16 billion, representing a 9.3% top-line beat. Non-GAAP gross margin expanded to 41.0%, up 180 basis points year-over-year from 39.2%. This was the sixth consecutive quarter in which Intel exceeded its own guidance.
The segment driving the most attention was Data Center and AI, where revenue climbed 22% year-over-year to $5.1 billion. AI-driven business now constitutes 60% of total revenue and grew 40% year-over-year — metrics that represent a fundamental repositioning of Intel’s revenue mix within a relatively compressed timeframe.
Q2 2026 guidance
Management guided Q2 2026 revenue to a range of $13.8 billion to $14.8 billion, versus the prior consensus of $13.07 billion — a midpoint beat of approximately $1.33 billion. Adjusted EPS guidance of $0.20 compared to prior consensus of $0.06–$0.09, representing a more than twofold beat at the midpoint of prior estimates.
Valuation and market cap
At $82.73 per share on 5.03 billion shares outstanding, Intel’s market capitalisation stands at $414.43 billion. The stock’s YTD gain of 124% compares to a 2025 full-year return of 84%, meaning shares have in four months already surpassed last year’s full-year appreciation. The 52-week range of $18.97–$85.22 represents a spread of more than 349%, reflecting the scale of both the prior decline and the subsequent recovery. Forward valuation metrics remain subject to wide dispersion given the pace of estimate revisions following this week’s results.
What analysts say
The analyst community entered the week divided and exited it in a state of rapid revision. The consensus rating across 30–39 covering analysts remains Hold, with a split of approximately 10–11 Buy ratings, 21–24 Hold ratings, and 3–6 Sell ratings. The average price target, however, has been rendered partially obsolete by the pace of post-earnings revisions, with figures ranging from a reported average of $49.68–$76.00 to a Street-high of $111.00 from Evercore ISI — all against a stock already trading at $82.73.
The week’s most consequential rating changes, as tracked by MarketWatch, included:
- Evercore ISI (April 24): Upgraded from In Line to Outperform; price target raised from $45 to $111. Analyst Mark Lipacis cited the CPU demand outlook and structural implications of agentic AI — the highest price target on the Street.
- Morgan Stanley (April 23): Upgraded from Equal Weight to Overweight, joining the bullish camp on the eve of the market’s reaction.
- Citigroup (April 24): Upgraded from Neutral to Buy, setting a $95 price target, anticipating a multi-year uplift in CPU sales across all major suppliers.
- HSBC (April 21): Upgraded from Hold to Buy ahead of earnings, raising the price target from $50 to $95. Analyst Frank Lee cited underappreciated server CPU momentum expected to materialise from Q2.
- Benchmark (April 24): Raised price target from $76 to $105, maintaining its Buy rating.
- Stifel (April 24): Raised price target from $65 to $75, maintaining a Hold rating. Analyst Ruben Roy’s more cautious stance reflects the broader consensus hesitation around execution risk at current valuation levels.
- Jefferies: Raised price target from $40 to $80, maintaining Hold.
- RBC Capital: Raised price target to $80, citing strong server demand and improving manufacturing yields.
- Susquehanna: Raised price target from $65 to $80, maintaining Neutral.
- KGI Securities (April 20): Cut from Outperform to Neutral, price target $71 — a pre-earnings downgrade now sitting below the current share price.
The persistence of Hold ratings — still the plurality of the consensus — alongside price targets from Stifel ($75), Jefferies ($80), RBC ($80), and Susquehanna ($80) that sit below or near the current share price suggests a meaningful portion of the analyst community views the post-earnings move as having priced in much of the near-term upside. The $20.00 low target from Baird, which remains on the books, stands as an outlier reflecting deep scepticism about Intel’s ability to sustain its manufacturing and competitive recovery.
For broader context on the macro environment into which Intel’s rally lands, PreMarket Daily’s Week Ahead preview for April 25 outlines the FOMC decision, Big Tech earnings, and core PCE data that will compete for market attention in the coming sessions.
Key levels, upcoming catalysts, and what changes the thesis
| Level / Event | Value | Signal |
|---|---|---|
| All-time intraday high | $85.22 | A sustained close above this level would mark new all-time high territory and may accelerate momentum-driven inflows |
| Street-high price target | $111.00 | Evercore ISI’s Outperform target; represents 34% upside from April 26 close if the agentic AI CPU thesis is validated over 12 months |
| Consensus Hold cluster | $75–$80 | Multiple Hold-rated analysts sit at this band; a retreat toward this zone could trigger reassessment of short-term momentum |
| Q2 2026 earnings date | ~July 2026 | Guidance of $13.8B–$14.8B revenue and $0.20 EPS sets a high bar; a miss would represent the first guidance shortfall in six consecutive quarters |
| 14A process / Terafab execution | 2026–2027 | Delays or yield issues in 14A production for Tesla, SpaceX, and xAI would directly challenge the foundry growth narrative underpinning bullish price targets |
The thesis that would most durably extend Intel’s re-rating rests on two pillars: continued CPU demand growth from agentic AI deployments, and successful execution on the 14A process node. The former is supported by management commentary and the Google partnership but remains contingent on AI adoption patterns that are still evolving. The latter is an engineering and manufacturing challenge that Intel has previously stumbled on, and which the Fab 34 buyout signals confidence in — at the cost of substantially increased financial leverage.
What would change the thesis negatively: a Q2 miss on revenue or margin, 14A yield or timeline slippage, renewed competitive pressure from TSMC or AMD in server CPUs, or a deterioration in AI infrastructure spending that reduces the urgency of CPU procurement alongside GPU buildouts. On the positive side, further conversions among the large Hold consensus to Buy ratings — particularly from analysts currently clustered at $75–$80 targets — could provide additional upward pressure on the stock if near-term execution continues to deliver.
Trading volume of 281.4 million shares on April 25 — 262% above the daily average of 107.64 million — underscores the degree to which institutional repositioning is still underway. PreMarket Daily’s Market Update section will track developments in real time as the week ahead brings FOMC, Big Tech earnings, and core PCE data into focus alongside Intel’s continued post-earnings consolidation.
This article is published by PreMarket Daily for informational purposes only. Nothing here constitutes financial advice, investment recommendations, or an offer to buy or sell any securities. Always consult a qualified financial professional before making investment decisions.
No Comment! Be the first one.